Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-052270
Filing Date
2005-03-16
Accepted
2005-03-16 11:59:42
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1075938
2 INDEMNITY AGREEMENT dex1023.htm EX-10.23 38798
3 EMPLOYMENT AGREEMENT BETWEEN VERSICOR INC. AND DAVID S. KRAUSE M.D. dex1032.htm EX-10.32 55178
4 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT FOR DAVID S. KRAUSE dex1035.htm EX-10.35 11686
5 STAEMENT RE: COMPUTATION OF RATIOS dex121.htm EX-12.1 4486
6 LIST OF SUBSIDIARIES dex211.htm EX-21.1 5080
7 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1703
8 SECTON 302 CEO CERTIFICATION dex311.htm EX-31.1 7704
9 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6608
10 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 5035
11 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 5074
  Complete submission text file 0001193125-05-052270.txt   1220286
Mailing Address 455 SOUTH GULPH ROAD SUITE 305 KING OF PRUSSIA PA 19406
Business Address 455 SOUTH GULPH ROAD SUITE 305 KING OF PRUSSIA PA 19406 610-491-2200
VICURON PHARMACEUTICALS INC (Filer) CIK: 0001052547 (see all company filings)

EIN.: 043278032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31145 | Film No.: 05684048
SIC: 2834 Pharmaceutical Preparations